A detailed history of Stanley Laman Group, Ltd. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 37,531 shares of NBIX stock, worth $4.71 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
37,531
Previous 27,443 36.76%
Holding current value
$4.71 Million
Previous $3.78 Million 14.35%
% of portfolio
0.67%
Previous 0.59%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$114.58 - $153.15 $1.16 Million - $1.54 Million
10,088 Added 36.76%
37,531 $4.32 Million
Q2 2024

Jul 18, 2024

BUY
$130.86 - $143.19 $3.59 Million - $3.93 Million
27,443 New
27,443 $3.78 Million
Q3 2018

Oct 30, 2018

SELL
$98.88 - $125.85 $8.89 Million - $11.3 Million
-89,884 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$75.3 - $105.99 $807,818 - $1.14 Million
10,728 Added 13.55%
89,884 $8.83 Million
Q1 2018

May 01, 2018

SELL
$75.88 - $92.43 $758,041 - $923,375
-9,990 Reduced 11.21%
79,156 $6.56 Million
Q4 2017

Feb 09, 2018

BUY
$58.53 - $77.59 $1.97 Million - $2.62 Million
33,723 Added 60.85%
89,146 $6.92 Million
Q3 2017

Nov 13, 2017

BUY
$47.97 - $61.28 $2.66 Million - $3.4 Million
55,423
55,423 $3.4 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Stanley Laman Group, Ltd. Portfolio

Follow Stanley Laman Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.